[Clinical Study on the Transition of First-Line Bortezomib Intole- rance to Carfilzomib in the Treatment of Multiple Myeloma]
{{output}}
Objective: To evaluate the feasibility of in-class transition（iCT） first-line bortezomib intolerance to carfilzomib in the treatment of patients with multiple myeloma（MM）. ... ...
